News | October 12, 2025
Samsung Biologics introduces optimized manufacturing framework ‘ExellenS’
ExellenS applies optimized facility designs, equipment, and processes across all sites to ensure equivalency and speed
ExellenS applies optimized facility designs, equipment, and processes across all sites to ensure equivalency and speed
PeptiGlow features premium-grade hydrolyzed collagen peptides that support skin elasticity and hydration
The new line features advanced isolator technology to deliver enhanced sterility assurance, throughput and operational precision
New filling line approval supports delivery of integrated, end-to-end solutions across the entire biologics and bioconjugates value chain
WHO’s global SPECS 2030 target to increase effective refractive error coverage by 40% by 2030
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
Conventional plasmids as a pharmaceutical material are not only suboptimal in safety and function, but exceedingly costly to produce, prohibitively
It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
Investment to expand manufacturing and global medicine supply capacity
Panacea Biotec receives Rs. 315 crore LoA from UNICEF
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
